TY - JOUR AU - Burnett, A. K. AU - Grimwade, D. AU - Solomon, E. AU - Wheatley, K. AU - Goldstone, A. H. PY - 1999 DA - 1999// TI - Presenting white blood cell count and kinetics of molecular remission predict prognosis in acute promyelocytic leukemia treated with all-trans retinoic acid: result of the randomized MRC trial JO - Blood VL - 93 ID - Burnett1999 ER - TY - JOUR AU - Shen, Z. X. AU - Chen, G. Q. AU - Ni, J. H. AU - Li, X. S. AU - Xiong, S. M. AU - Qiu, Q. Y. PY - 1997 DA - 1997// TI - Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients JO - Blood VL - 89 ID - Shen1997 ER - TY - JOUR AU - Soignet, S. L. AU - Maslak, P. AU - Wang, Z. G. AU - Jhanwar, S. AU - Calleja, E. AU - Dardashti, L. J. PY - 1998 DA - 1998// TI - Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide JO - N Engl J Med VL - 339 UR - https://doi.org/10.1056/NEJM199811053391901 DO - 10.1056/NEJM199811053391901 ID - Soignet1998 ER - TY - JOUR AU - Miyawaki, S. AU - Ohtake, S. AU - Fujisawa, S. AU - Kiyoi, H. AU - Shinagawa, K. AU - Usui, N. PY - 2011 DA - 2011// TI - A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 study JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-07-295279 DO - 10.1182/blood-2010-07-295279 ID - Miyawaki2011 ER - TY - JOUR AU - Miyawaki, S. AU - Sakamaki, H. AU - Ohtake, S. AU - Emi, N. AU - Yagasaki, F. AU - Mitani, K. PY - 2005 DA - 2005// TI - A randomized, postremission comparison of four courses of standard-dose consolidation therapy without maintenance therapy versus three courses of standard-dose consolidation with maintenance therapy in adults with acute myeloid leukemia: the Japan adult leukemia study group AML 97 study JO - Cancer VL - 104 UR - https://doi.org/10.1002/cncr.21493 DO - 10.1002/cncr.21493 ID - Miyawaki2005 ER - TY - JOUR AU - Ohtake, S. AU - Miyawaki, S. AU - Fujita, H. AU - Kiyoi, H. AU - Shinagawa, K. AU - Usui, N. PY - 2011 DA - 2011// TI - Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 study JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-03-273243 DO - 10.1182/blood-2010-03-273243 ID - Ohtake2011 ER - TY - JOUR AU - Mayer, E. L. AU - Krop, I. E. PY - 2010 DA - 2010// TI - Advances in targeting SRC in the treatment of breast cancer and other solid malignancies JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-1834 DO - 10.1158/1078-0432.CCR-09-1834 ID - Mayer2010 ER - TY - JOUR AU - Amrein, P. C. PY - 2011 DA - 2011// TI - The potential for dasatinib in treating chronic lymphocytic leukemia, acute myeloid leukemia, and myeloproliferative neoplasms JO - Leuk Lymphoma VL - 52 UR - https://doi.org/10.3109/10428194.2011.555890 DO - 10.3109/10428194.2011.555890 ID - Amrein2011 ER - TY - JOUR AU - Meyn, M. A. AU - Schreiner, S. J. AU - Dumitrescu, T. P. AU - Nau, G. J. AU - Smithgall, T. E. PY - 2005 DA - 2005// TI - SRC family kinase activity is required for murine embryonic stem cell growth and differentiation JO - Mol Pharmacol VL - 68 UR - https://doi.org/10.1124/mol.104.010231 DO - 10.1124/mol.104.010231 ID - Meyn2005 ER - TY - JOUR AU - Santos, C. AU - Demur, C. AU - Bardet, V. AU - Prade-Houdellier, N. AU - Payrastre, B. AU - Recher, C. PY - 2008 DA - 2008// TI - A critical role for Lyn in acute myeloid leukemia JO - Blood VL - 111 UR - https://doi.org/10.1182/blood-2007-04-082099 DO - 10.1182/blood-2007-04-082099 ID - Santos2008 ER - TY - JOUR AU - Guerrouahen, B. S. AU - Futami, M. AU - Vaklavas, C. AU - Kanerva, J. AU - Whichard, Z. L. AU - Nwawka, K. PY - 2010 DA - 2010// TI - Dasatinib inhibits the growth of molecularly heterogeneous myeloid leukemias JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-2416 DO - 10.1158/1078-0432.CCR-09-2416 ID - Guerrouahen2010 ER - TY - JOUR AU - Kropf, P. L. AU - Wang, L. AU - Zang, Y. AU - Redner, R. L. AU - Johnson, D. E. PY - 2010 DA - 2010// TI - Dasatinib promotes ATRA-induced differentiation of AML cells JO - Leukemia VL - 24 UR - https://doi.org/10.1038/leu.2009.267 DO - 10.1038/leu.2009.267 ID - Kropf2010 ER - TY - JOUR AU - Wu, J. AU - Meng, F. AU - Kong, L. Y. AU - Peng, Z. AU - Ying, Y. AU - Bornmann, W. G. PY - 2008 DA - 2008// TI - Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase JO - J Natl Cancer Inst VL - 100 UR - https://doi.org/10.1093/jnci/djn188 DO - 10.1093/jnci/djn188 ID - Wu2008 ER - TY - JOUR AU - Congleton, J. AU - MacDonald, R. AU - Yen, A. PY - 2012 DA - 2012// TI - Src inhibitors, PP2 and dasatinib, increase retinoic acid-induced association of Lyn and c-Raf (S259) and enhance MAPK-dependent differentiation of myeloid leukemia cells JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2011.390 DO - 10.1038/leu.2011.390 ID - Congleton2012 ER - TY - JOUR AU - Klamova, H. AU - Faber, E. AU - Zackova, D. AU - Markova, M. AU - Voglova, J. AU - Cmunt, E. PY - 2010 DA - 2010// TI - Dasatinib in imatinib-resistant or -intolerant CML patients: data from the clinical practice of 6 hematological centers in the Czech Republic JO - Neoplasma VL - 57 ID - Klamova2010 ER - TY - JOUR AU - Papageorgiou, S. G. AU - Pappa, V. AU - Economopoulou, C. AU - Tsirigotis, P. AU - Konsioti, F. AU - Ionnidou, E. D. PY - 2010 DA - 2010// TI - Dasatinib induces long-term remission in imatinib-resistant Philadelphia chromosome-positive acute megakaryoblastic leukemia but fails to prevent development of central nervous system progression JO - Leuk Res VL - 34 UR - https://doi.org/10.1016/j.leukres.2010.03.032 DO - 10.1016/j.leukres.2010.03.032 ID - Papageorgiou2010 ER - TY - JOUR AU - Kikuchi, H. AU - Yuan, B. AU - Nishimura, Y. AU - Imai, M. AU - Furutani, R. AU - Kamoi, S. PY - 2013 DA - 2013// TI - Cytotoxicity of Vitex agnus-castus fruit extract and its major component, casticin, correlates with differentiation status in leukemia cell lines JO - Int J Oncol VL - 43 ID - Kikuchi2013 ER - TY - JOUR AU - Collins, S. J. PY - 1987 DA - 1987// TI - The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression JO - Blood VL - 70 ID - Collins1987 ER - TY - JOUR AU - Sears, R. C. PY - 2004 DA - 2004// TI - The life cycle of C-myc: from synthesis to degradation JO - Cell cycle VL - 3 UR - https://doi.org/10.4161/cc.3.9.1145 DO - 10.4161/cc.3.9.1145 ID - Sears2004 ER - TY - JOUR AU - Coppola, J. A. AU - Cole, M. D. PY - 1986 DA - 1986// TI - Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment JO - Nature VL - 320 UR - https://doi.org/10.1038/320760a0 DO - 10.1038/320760a0 ID - Coppola1986 ER - TY - JOUR AU - Jiang, G. AU - Albihn, A. AU - Tang, T. AU - Tian, Z. AU - Henriksson, M. PY - 2008 DA - 2008// TI - Role of Myc in differentiation and apoptosis in HL60 cells after exposure to arsenic trioxide or all-trans retinoic acid JO - Leuk Res VL - 32 UR - https://doi.org/10.1016/j.leukres.2007.06.021 DO - 10.1016/j.leukres.2007.06.021 ID - Jiang2008 ER - TY - JOUR AU - Nguyen, H. Q. AU - Selvakumaran, M. AU - Liebermann, D. A. AU - Hoffman, B. PY - 1995 DA - 1995// TI - Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells JO - Oncogene VL - 11 ID - Nguyen1995 ER - TY - JOUR AU - Cheng, Y. C. AU - Lin, H. AU - Huang, M. J. AU - Chow, J. M. AU - Lin, S. AU - Liu, H. E. PY - 2007 DA - 2007// TI - Downregulation of c-Myc is critical for valproic acid-induced growth arrest and myeloid differentiation of acute myeloid leukemia JO - Leuk Res VL - 31 UR - https://doi.org/10.1016/j.leukres.2007.03.012 DO - 10.1016/j.leukres.2007.03.012 ID - Cheng2007 ER - TY - JOUR AU - Grosso, L. E. AU - Pitot, H. C. PY - 1985 DA - 1985// TI - Transcriptional regulation of c-myc during chemically induced differentiation of HL-60 cultures JO - Cancer Res VL - 45 ID - Grosso1985 ER - TY - JOUR AU - Hoffman, B. AU - Amanullah, A. AU - Shafarenko, M. AU - Liebermann, D. A. PY - 2002 DA - 2002// TI - The proto-oncogene c-myc in hematopoietic development and leukemogenesis JO - Oncogene VL - 21 UR - https://doi.org/10.1038/sj.onc.1205400 DO - 10.1038/sj.onc.1205400 ID - Hoffman2002 ER - TY - JOUR AU - Katagiri, K. AU - Katagiri, T. AU - Koyama, Y. AU - Morikawa, M. AU - Yamamoto, T. AU - Yoshida, T. PY - 1991 DA - 1991// TI - Expression of src family genes during monocytic differentiation of HL-60 cells JO - J Immunol VL - 146 ID - Katagiri1991 ER - TY - JOUR AU - Imran, M. AU - Park, T. J. AU - Lim, I. K. PY - 2012 DA - 2012// TI - TIS21/BTG2/PC3 enhances downregulation of c-Myc during differentiation of HL-60 cells by activating Erk1/2 and inhibiting Akt in response to all-trans-retinoic acid JO - Eur J Cancer VL - 48 UR - https://doi.org/10.1016/j.ejca.2012.01.028 DO - 10.1016/j.ejca.2012.01.028 ID - Imran2012 ER - TY - JOUR AU - Sears, R. AU - Nuckolls, F. AU - Haura, E. AU - Taya, Y. AU - Tamai, K. AU - Nevins, J. R. PY - 2000 DA - 2000// TI - Multiple Ras-dependent phosphorylation pathways regulate Myc protein stability JO - Genes Dev VL - 14 UR - https://doi.org/10.1101/gad.836800 DO - 10.1101/gad.836800 ID - Sears2000 ER - TY - JOUR AU - Yeh, E. AU - Cunningham, M. AU - Arnold, H. AU - Chasse, D. AU - Monteith, T. AU - Ivaldi, G. PY - 2004 DA - 2004// TI - A signalling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells JO - Nat Cell Biol VL - 6 UR - https://doi.org/10.1038/ncb1110 DO - 10.1038/ncb1110 ID - Yeh2004 ER - TY - JOUR AU - Iriyama, N. AU - Yuan, B. AU - Yoshino, Y. AU - Hatta, Y. AU - Horikoshi, A. AU - Aizawa, S. PY - 2014 DA - 2014// TI - Enhancement of differentiation induction and upregulation of CCAAT/enhancer-binding proteins and PU.1 in NB4 cells treated with combination of ATRA and valproic acid JO - Int J Oncol VL - 44 ID - Iriyama2014 ER - TY - JOUR AU - Iriyama, N. AU - Yuan, B. AU - Hatta, Y. AU - Horikoshi, A. AU - Yoshino, Y. AU - Toyoda, H. PY - 2012 DA - 2012// TI - Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A JO - Oncol Rep VL - 28 ID - Iriyama2012 ER - TY - JOUR AU - Iriyama, N. AU - Yuan, B. AU - Yoshino, Y. AU - Hatta, Y. AU - Horikoshi, A. AU - Aizawa, S. PY - 2013 DA - 2013// TI - Aquaporin 9, a promising predictor for the cytocidal effects of arsenic trioxide in acute promyelocytic leukemia cell lines and primary blasts JO - Oncol Rep VL - 29 ID - Iriyama2013 ER - TY - JOUR AU - Iriyama, N. AU - Hatta, Y. AU - Takei, M. PY - 2015 DA - 2015// TI - ETV6/ARG oncoprotein confers autonomous cell growth by enhancing c-Myc expression via signal transducer and activator of transcription 5 activation in the acute promyelocytic leukemia cell line HT93A JO - Leuk Lymphoma VL - 56 UR - https://doi.org/10.3109/10428194.2014.982643 DO - 10.3109/10428194.2014.982643 ID - Iriyama2015 ER - TY - JOUR AU - Ruan, X. Z. AU - Varghese, Z. AU - Powis, S. H. AU - Moorhead, J. F. PY - 1999 DA - 1999// TI - Human mesangial cells express inducible macrophage scavenger receptor JO - Kidney Int VL - 56 UR - https://doi.org/10.1046/j.1523-1755.1999.00587.x DO - 10.1046/j.1523-1755.1999.00587.x ID - Ruan1999 ER - TY - JOUR AU - Grimwade, D. AU - Walker, H. AU - Oliver, F. AU - Wheatley, K. AU - Harrison, C. AU - Harrison, G. PY - 1998 DA - 1998// TI - The importance of diagnostic cytogenetics on outcome in AML: analysis of 1612 patients entered into the MRC AML 10 trial. The medical research council adult and children’s leukaemia working parties JO - Blood VL - 92 ID - Grimwade1998 ER - TY - JOUR AU - Pakkala, S. AU - Vos, S. AU - Elstner, E. AU - Rude, R. K. AU - Uskokovic, M. AU - Binderup, L. PY - 1995 DA - 1995// TI - Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels JO - Leuk Res VL - 19 UR - https://doi.org/10.1016/0145-2126(94)00065-I DO - 10.1016/0145-2126(94)00065-I ID - Pakkala1995 ER - TY - JOUR AU - Koeffler, H. P. AU - Hirji, K. AU - Itri, L. PY - 1985 DA - 1985// TI - 1,25-dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells JO - Cancer Treat Rep VL - 69 ID - Koeffler1985 ER - TY - JOUR AU - Li, Y. J. AU - He, Y. F. AU - Han, X. H. AU - Hu, B. PY - 2015 DA - 2015// TI - Dasatinib suppresses invasion and induces apoptosis in nasopharyngeal carcinoma JO - Int J Clin Exp Pathol VL - 8 ID - Li2015 ER - TY - JOUR AU - Chen, J. AU - Lan, T. AU - Zhang, W. AU - Dong, L. AU - Kang, N. AU - Fu, M. PY - 2015 DA - 2015// TI - Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways JO - Arch Biochem Biophys VL - 575 UR - https://doi.org/10.1016/j.abb.2014.11.008 DO - 10.1016/j.abb.2014.11.008 ID - Chen2015 ER - TY - JOUR AU - Santos, C. AU - McDonald, T. AU - Ho, Y. W. AU - Liu, H. AU - Lin, A. AU - Forman, S. J. PY - 2013 DA - 2013// TI - The Src and c-Kit kinase inhibitor dasatinib enhances p53-mediated targeting of human acute myeloid leukemia stem cells by chemotherapeutic agents JO - Blood VL - 122 UR - https://doi.org/10.1182/blood-2012-11-466425 DO - 10.1182/blood-2012-11-466425 ID - Santos2013 ER -